Skip to main content
Log in

Imaging and osteoarthritis: What is the predictive value?

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Recent protocols for standardized knee radiography, which attempts to image the knee with reproducible, parallel alignment of the medial tibial plateau and radiograph beam, possess many theoretic advantages. As a group, they permit measurement of tibiofemoral joint space width with remarkable precision—the sine qua non of sensitive detection of change. However, only limited longitudinal data are available in peer-reviewed publications to permit a direct evaluation of the suitability of these protocols for use in multicenter clinical trials and studies of biomarkers of osteoarthritis (OA) progression. Longitudinal data from several National Institutes of Health-supported studies of OA progression, as reflected in radiographs acquired with high levels of standardization for radioanatomic positioning of the knee, should be available in the next several years. Alternatively, data from the placebo groups of several industry-supported phase III trials of purported diseasemodifying OA drugs, which were terminated prematurely because of adverse events or lack of efficacy, may be made available for rapid analysis regarding the performance of current standardization protocols with respect to their sensitivity to disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Bellamy N, Kirwan J, Boers M, et al.: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis Consensus development at OMERACT III. J Rheumatol 1997, 24:799–802.

    PubMed  CAS  Google Scholar 

  2. Altman R, Brandt K, Hochberg M, et al.: Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cartilage 2003, 4:217–243.

    Article  Google Scholar 

  3. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health: Draft Guidance for Industry: Clinical Development Programs for Drugs, Devices, and Biological Products Intended for the Treatment of Osteoarthritis. Rockville, MD; July 1999.

  4. Buckland-Wright JC, Macfarlane DG, Lynch JA, et al.: Joint space width measures cartilage thickness in osteoarthritis of the knee: high resolution plain film and double contrast macroradiographic investigation. Ann Rheum Dis 1995, 54:263–268.

    Article  PubMed  CAS  Google Scholar 

  5. Brandt KD, Mazzuca SA, Conrozier T, et al.: Which is the best radiographic protocol for a clinical trial of a structure-modifying drug in patients with knee osteoarthritis? Proceedings of January 17–18, 2002 workshop in Toussus-le-Noble, France. J Rheumatol 2002, 29:1308–1320. NEGMA-LERADS convened an ad hoc advisory board to discuss the current status of radiographic techniques for DMOAD studies in patients with knee OA. The participants, all of whom had developed relevant methodologies and had generated data relevant to imaging of the OA knee that had been published in peer-reviewed journals, reviewed the scientific evidence, and drew indicated conclusions regarding whether any radiographic protocols can be recommended for use in DMOAD studies of reasonable size and duration to demonstrate the efficacy of a drug that slows the rate of loss of articular cartilage in patients with knee OA.

    PubMed  Google Scholar 

  6. Ahlback S: Osteoarthritis of the knee: a radiographic investigation. Acta Radiol 1968, 277(suppl):7–72.

    Google Scholar 

  7. Mazzuca SA, Brandt KD, Katz BP: Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee osteoarthritis? Osteoarthritis Cartilage 1997, 5:217–226.

    Article  PubMed  CAS  Google Scholar 

  8. Mazzuca SA, Brandt KD, Dieppe PA, et al.: Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph. Arthritis Rheum 2001, 44:1786–1794. This study of conventional standing AP radiographs in OA research cohorts from the US and UK shows how the lack of standards for radioanatomic positioning of the knee in previous studies of the knee OA may obscure the true rate and variability of JSN. In contrast, detection of changes in the size of marginal osteophytes was not affected by uncontrolled changes in the position of the knee in serial standing AP radiographs.

    Article  PubMed  CAS  Google Scholar 

  9. Reginster JY, Deroisy R, Rovati LC, et al.: Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 2001, 357:251–256. This study was a 3-year randomized controlled trial of the effect of glucosamine sulfate on radiographic JSN in knee OA, as reflected in the conventional standing AP view. The authors concluded that treatment with glucosamine sulfate slowed the progression of knee OA and decreased knee pain and disability in comparison with treatment with placebo.

    Article  PubMed  CAS  Google Scholar 

  10. Mazzuca SA, Brandt KD, Buckwalter KA, et al.: Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees. Arthritis Rheum 2002, 46:1223–1227. This small clinical study provides evidence that changes in OA knee pain can alter the appearance of radiographic JSW in OA knees in the standing AP view. These data are relevant to clinical trials of the disease-modifying and symptomatic effects of purported DMOADs when radiographic outcomes are derived from the conventional standing AP view. Systematic reduction of symptoms in the active treatment group may permit subjects randomized to that group to extend the knee more fully than was possible in earlier examination(s), which will increase the appearance of the radiographic joint space. This may exaggerate the difference between treatment groups with respect to JSN.

    Article  PubMed  Google Scholar 

  11. Buckland-Wright JC, Macfarlane DG, Williams SA, et al.: Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees. Ann Rheum Dis 1995, 54:872–880.

    PubMed  CAS  Google Scholar 

  12. Piperno M, Hellio Le Graverand M-P, Conrozier T, et al.: Quantitative evaluation of joint space width in femorotibial osteoarthritis: comparison of three radiographic views. Osteoarthritis Cartilage 1998, 6:252–259.

    Article  PubMed  CAS  Google Scholar 

  13. Buckland-Wright JC, Wolfe F, Ward RJ, et al.: Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed AP, and schuss views. J Rheumatol 1999, 26:2664–2674. This is the first published description of the reproducibility of joint positioning and measurement of JSW in radiographs obtained by a non-fluoroscopically assisted protocol for standardized knee radiography (ie, the MTP view). This study is significant in that it demonstrates that skewed alignment of the medial tibial plateau and radiograph beam need not preclude precise measurement of JSW if the same degree of misalignment is reproduced in repeated examinations on the same day. However, no data on the longitudinal reproducibility of positioning for the MTP view are presented.

    PubMed  CAS  Google Scholar 

  14. Peterfy CG, Li J, Duryea J, et al.: Nonfluoroscopic method for flexed radiography of the knee allows reproducible joint space width measurement. Arthritis Rheum 1998, 41(suppl):S361. An alternative protocol for non-fluoroscopically assisted standardized knee radiography, the fixed-flexion view is notable for its method for positioning the subject in a way that fixed the femorotibial angle— an element of positioning not addressed by most standardization protocols. A description of the short-term reproducibility of this protocol has only appeared in abstract form.

    Article  Google Scholar 

  15. Mazzuca SA, Brandt KD, Buckland-Wright JC, et al.: Field test of the reproducibility of automated measurements of medial tibiofemoral joint space width derived from standardized knee radiographs. J Rheumatol 1999, 26:1359–1365. This field test of the semiflexed AP view illustrates the extent to which the reproducibility of a protocol for standardizing the radioanatomic position of the knee, as originally determined under ideal conditions, may decrease somewhat when transported for use in clinical radiology departments, such as those that participate in multicenter studies of the radiographic progression of OA.

    PubMed  CAS  Google Scholar 

  16. Dieppe PA, Cushnaghan J, Shepstone L: The Bristol ’OA500’ Study: progression of osteoarthritis over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage 1997, 5:87–97.

    Article  PubMed  CAS  Google Scholar 

  17. Kirwan JR, Cushnaghan J, Dacre J, et al.: Progression of joint space narrowing in knee osteoarthritis. Arthritis Rheum 1992, 35(suppl):S134.

    Google Scholar 

  18. Mazzuca SA, Brandt KD, Buckwalter KA, et al.: Field test of the reproducibility of the semiflexed metatarsophalangeal (MTP) view in repeated radiographic examinations of subjects with osteoarthritis of the knee. Arthritis Rheum 2002, 46:109–113. This study confirms that the non-fluoroscopically assisted MTP view can be implemented in a clinical research center with short-term reproducibility similar to that associated with protocols using fluoroscopy to standardize positioning of the knee.

    Article  PubMed  Google Scholar 

  19. Messieh SS, Fowler PJ, Munro T: Anteroposterior radiographs of the osteoarthritic knee: J Bone Joint Surg 1990, 72B:639–640.

    Google Scholar 

  20. Brown PD: Ongoing trials with matrix metalloproteinase inhibitors. Exp Opin Invest Drugs 2000, 9:2167–2177.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazzuca, S.A. Imaging and osteoarthritis: What is the predictive value?. Curr Rheumatol Rep 5, 27–32 (2003). https://doi.org/10.1007/s11926-003-0080-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-003-0080-y

Keywords

Navigation